Jeng-Wei Lu1, Yen-Shuo Tseng2, Yu-Sheng Lo3, Yueh-Min Lin4,5, Chung-Min Yeh5,6, Shu-Hui Lin5,7. 1. Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore. 2. Department of Dermatology, Changhua Christian Hospital, Changhua 500, Taiwan. 3. Department of Oral Cancer Research Center, Changhua Christian Hospital, Changhua 500, Taiwan. 4. School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. 5. Department of Surgical Pathology, Changhua Christian Hospital, Changhua 500, Taiwan. 6. Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356, Taiwan. 7. Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung 406, Taiwan.
Abstract
Background and Objectives: Oral squamous cell carcinoma (OSCC) is a malignant disease with a particularly high incidence in Taiwan. Our objective in this study was to elucidate the involvement of sphingolipid transporter 2 (SPNS2) expression and SPNS2 protein expression in the clinicopathological indexes and the clinical outcomes of OSCC patients. Materials and Methods: Immunohistochemistry analysis was performed for SPNS2 protein expression in samples from 264 cases of OSCC. Correlations of SPNS2 expression with clinicopathological variables and patient survival were analyzed. Results: Our results revealed that the cytoplasmic protein expression of SPNS2 in OSCC tissue specimens was lower than in normal tissue specimens. Negative cytoplasmic protein expression of SPNS2 was significantly correlated with T status and stage. Kaplan-Meier survival curve analysis revealed that negative cytoplasmic SPNS2 expression was predictive of poorer overall survival of OSCC patients in stage III/IV. We also determined that low SPNS2 expression was an independent prognostic factor related to overall survival among OSCC patients in stage III/IV from univariate Cox proportional hazard models. Multivariate Cox proportional hazard models revealed that cytoplasmic SPNS2 expression, T status, lymph node metastasis, and histological grade were independent prognostic factors for survival. Conclusions: Overall, this study determined that SPNS2 protein may be a useful prognostic marker for OSCC patients and potential therapeutic target for OSCC treatment.
Background and Objectives: Oral squamous cell carcinoma (OSCC) is a malignant disease with a particularly high incidence in Taiwan. Our objective in this study was to elucidate the involvement of sphingolipid transporter 2 (SPNS2) expression and SPNS2 protein expression in the clinicopathological indexes and the clinical outcomes of OSCC patients. Materials and Methods: Immunohistochemistry analysis was performed for SPNS2 protein expression in samples from 264 cases of OSCC. Correlations of SPNS2 expression with clinicopathological variables and patient survival were analyzed. Results: Our results revealed that the cytoplasmic protein expression of SPNS2 in OSCC tissue specimens was lower than in normal tissue specimens. Negative cytoplasmic protein expression of SPNS2 was significantly correlated with T status and stage. Kaplan-Meier survival curve analysis revealed that negative cytoplasmic SPNS2 expression was predictive of poorer overall survival of OSCC patients in stage III/IV. We also determined that low SPNS2 expression was an independent prognostic factor related to overall survival among OSCC patients in stage III/IV from univariate Cox proportional hazard models. Multivariate Cox proportional hazard models revealed that cytoplasmic SPNS2 expression, T status, lymph node metastasis, and histological grade were independent prognostic factors for survival. Conclusions: Overall, this study determined that SPNS2 protein may be a useful prognostic marker for OSCC patients and potential therapeutic target for OSCC treatment.
Authors: Tomoyuki Sasaki; Shanshan Lian; Alam Khan; Jesse R Llop; Andrew V Samuelson; Wenbiao Chen; Daniel J Klionsky; Shuji Kishi Journal: Autophagy Date: 2016-11-22 Impact factor: 16.016
Authors: Masayuki Nagahashi; Subramaniam Ramachandran; Eugene Y Kim; Jeremy C Allegood; Omar M Rashid; Akimitsu Yamada; Renping Zhao; Sheldon Milstien; Huiping Zhou; Sarah Spiegel; Kazuaki Takabe Journal: Cancer Res Date: 2012-02-01 Impact factor: 12.701